Viive M Howell

9PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 13, 2024
CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

Amanda L Hudson, Angela Cho, Emily K Colvin

|Aug 12, 2022
An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma.

Emily K Colvin, Amanda L Hudson, Lyndsey L Anderson

|Jul 27, 2022
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer.

Christopher B Nahm, John Turchini, Sumit Sahni

|Sep 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Katherine B Sahin, Esha T Shah, Genevieve P Ferguson

|Jul 02, 2021
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.

Sarah Maloney, Malinda Itchins, Jennifer Arena

|Mar 06, 2021
Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Archana Prashanth, Heather Donaghy, Shihani P Stoner

Pageof 2

Frequent Collaborators

2 joint publications

Sumit Sahni

2 joint publications

Anubhav Mittal

1 joint publications

Archana Prashanth

1 joint publications

Heather Donaghy